Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.18 is 91% below its 5-year average of 1.97, near the low end of its 5-year range (0.18–6.70).
As of the fiscal period ended Tuesday, June 30, 2026. 73.16% below its 12-month average of 0.67.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18.
CURRENT RATIO
0.18
CURRENT RATIO AVG TTM
0.67
CURRENT RATIO AVG 3Y
0.70
CURRENT RATIO AVG 5Y
1.97
CURRENT RATIO AVG 10Y
3.39
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-73.16%
CURRENT VS 3Y AVG
-74.44%
CURRENT VS 5Y AVG
-90.92%
CURRENT VS 10Y AVG
-94.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-95.00%
vs the sector median at left
TuHURA Biosciences, Inc.
Market Cap
$121.95M
Current Ratio
0.18
TTM Avg
0.67
3Y Avg
0.70
5Y Avg
1.97
Market Cap
$122.26M
Current Ratio
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$123.16M
Current Ratio
9.23
TTM Avg
4.04
3Y Avg
4.74
5Y Avg
7.63
Market Cap
$125.12M
Current Ratio
0.86
TTM Avg
0.23
3Y Avg
0.62
5Y Avg
0.88
Market Cap
$118.05M
Current Ratio
13.55
TTM Avg
17.30
3Y Avg
10.78
5Y Avg
9.73
Market Cap
$117.05M
Current Ratio
13.40
TTM Avg
10.04
3Y Avg
7.53
5Y Avg
8.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $121.95M | 0.18 | 0.67 | 0.70 | 1.97 |
| Cibus, Inc. (CBUS)vs › | $121.75M | 1.62 | 0.78 | 1.43 | 2.42 |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | 10.21 | 11.59 | 10.00 | 8.96 |
| Seer, Inc. (SEER)vs › | $121.01M | 14.74 | 14.69 | 22.23 | 28.85 |
| Spruce Biosciences, Inc. (SPRB)vs › | $123.16M | 9.23 | 4.04 | 4.74 | 7.63 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.12M | 0.86 | 0.23 | 0.62 | 0.88 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.05M | 13.55 | 17.30 | 10.78 | 9.73 |
| Entera Bio Ltd. (ENTX)vs › | $126.43M | 8.98 | 5.43 | 7.69 | 7.29 |
| Coya Therapeutics, Inc. (COYA)vs › | $117.05M | 13.40 | 10.04 | 7.53 | 8.95 |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.03M | 6.49 | 6.44 | 8.52 | 8.53 |
Current Ratio
0.18
Quick Ratio
0.18
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.18 |
| 2026-03-31 | 1.15 |
| 2025-12-31 | 0.78 |
| 2025-09-30 | 0.40 |
| 2025-06-30 | 0.83 |
| 2025-03-31 | 3.00 |
| 2024-12-31 | 3.68 |
| 2024-09-30 | 0.64 |
| 2024-06-30 | 2.45 |
| 2024-03-31 | 1.09 |
| 2023-12-31 | 0.63 |
| 2023-09-30 | 0.23 |
| 2023-06-30 | 1.06 |
| 2023-03-31 | 3.09 |
| 2022-12-31 | 2.83 |
| 2022-09-30 | 2.32 |
| 2022-06-30 | 3.32 |
| 2022-03-31 | 3.12 |
| 2021-12-31 | 4.36 |
| 2021-09-30 | 6.70 |
| 2021-06-30 | 4.24 |
| 2021-03-31 | 6.55 |
| 2020-12-31 | 6.50 |
| 2020-09-30 | 9.61 |
| 2020-06-30 | 1.03 |
| 2020-03-31 | 3.69 |
| 2019-12-31 | 6.33 |
| 2019-09-30 | 6.24 |
| 2019-06-30 | 1.94 |
| 2019-03-31 | 2.01 |
| 2018-12-31 | 1.94 |
| 2018-09-30 | 4.39 |
| 2018-06-30 | 4.30 |
| 2018-03-31 | 4.79 |
| 2017-12-31 | 4.30 |
| 2017-09-30 | 9.45 |
| 2017-06-30 | 6.03 |
| 2017-03-31 | 2.25 |
| 2016-12-31 | 4.95 |
| 2016-09-30 | 10.40 |
